​

Neuphoria Therapeutics Ownership | Who Owns Neuphoria Therapeutics?

OverviewChart

Neuphoria Therapeutics Ownership Summary

Neuphoria Therapeutics is owned by 8.91% institutional investors, 33.91% insiders, and 57.18% retail investors. Armistice capital is the largest institutional shareholder, holding 12.93% of NEUP shares.

NEUP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNeuphoria Therapeutics8.91%33.91%57.18%
SectorHealthcare Stocks 487.91%11.08%-398.99%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Armistice capital1.23M12.93%$940.92K
Lynx1 capital management lp599.67K6.32%$459.95K
Point72 asset management316.00K3.33%$242.37K
Ubs group34.90K0.37%$26.77K
Two sigma investments, lp16.37K0.17%$12.56K
Rhumbline advisers2.19K0.02%$1.68K
Morgan stanley794.000.01%$609.00
Aspire private capital200.000.00%$153.00
Jpmorgan chase1.00-$1.00
Beacon pointe advisors---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lynx1 capital management lp599.67K0.03%$459.95K
Armistice capital1.23M0.01%$940.92K
Point72 asset management316.00K0.00%$242.37K
Two sigma investments, lp16.37K-$12.56K
Rhumbline advisers2.19K-$1.68K
Aspire private capital200.00-$153.00
Beacon pointe advisors---
Jpmorgan chase1.00-$1.00
Ubs group34.90K-$26.77K
Xtx topco---

Top Buyers

HolderShares% AssetsChange
Armistice capital1.23M0.01%1.23M
Ubs group34.90K-24.96K
Rhumbline advisers2.19K-890.00
Morgan stanley794.00-700.00
Aspire private capital200.00--

Top Sellers

HolderShares% AssetsChange
Lynx1 capital management lp599.67K0.03%-214.79K
Two sigma securities---26.04K
Lewis asset management---23.00K
Xtx topco---10.94K
Beacon pointe advisors---10.00K

New Positions

HolderShares% AssetsChangeValue
Armistice capital1.23M0.01%1.23M$940.92K

Sold Out

HolderChange
Beacon pointe advisors-10.00K
Xtx topco-10.94K
Lewis asset management-23.00K
Two sigma securities-26.04K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20248-38.46%2,502,50810.39%81.56%5-28.57%1-50.00%
Jun 30, 20241330.00%2,266,86791.45%2315.34%740.00%2-50.00%
Mar 31, 20241011.11%1,184,070-8.64%124.95%5-4100.00%
Dec 31, 20239-18.18%1,296,018-46.32%151.54%5-50.00%2100.00%
Sep 30, 202311266.67%2,414,424823.59%32265.64%10-1-50.00%

Recent Insider Transactions

DateNameRoleActivityValue
Oct 21, 2025Lynx1 Capital Management LP-Buy$3.28M

Insider Transactions Trends

DateBuySell
2025 Q41-
2025 Q3--
2025 Q2--

NEUP Ownership FAQ

Who owns the most shares of Neuphoria Therapeutics?

Neuphoria Therapeutics’s largest shareholders are Armistice capital (1.23M shares, 12.93%), Lynx1 capital management lp (599.67K shares, 6.32%), and Point72 asset management (316K shares, 3.33%). Together, they hold 22.58% of Neuphoria Therapeutics’s total shares outstanding.

Does Blackrock own Neuphoria Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Neuphoria Therapeutics.

Who is Neuphoria Therapeutics’s biggest shareholder by percentage of total assets invested?

Lynx1 capital management lp is Neuphoria Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 599.67K Neuphoria Therapeutics shares, valued at 459.95K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools